ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Emcure Pharmaceuticals received an Establishment Inspection Report (EIR) from the USFDA, classifying its Sanand facility inspection as 'Voluntary Action Indicated' and effectively closing the inspection.
Emcure Pharmaceuticals concluded a US FDA inspection at its Sanand facility with seven procedural observations. The company will address these within the stipulated timeframe.